Global Oncology Targeted Therapy Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Targeted Therapy Market Size 2017-2028
2.1.2 Oncology Targeted Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oncology Targeted Therapy Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Oncology Targeted Therapy Market Size by Type
2.3.1 Oncology Targeted Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
2.4 Oncology Targeted Therapy Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Oncology Targeted Therapy Market Size by Application
2.5.1 Oncology Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
3 Oncology Targeted Therapy Market Size by Player
3.1 Oncology Targeted Therapy Market Size Market Share by Players
3.1.1 Global Oncology Targeted Therapy Revenue by Players (2020-2022)
3.1.2 Global Oncology Targeted Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Oncology Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Targeted Therapy by Regions
4.1 Oncology Targeted Therapy Market Size by Regions (2017-2022)
4.2 Americas Oncology Targeted Therapy Market Size Growth (2017-2022)
4.3 APAC Oncology Targeted Therapy Market Size Growth (2017-2022)
4.4 Europe Oncology Targeted Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Oncology Targeted Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Oncology Targeted Therapy Market Size by Country (2017-2022)
5.2 Americas Oncology Targeted Therapy Market Size by Type (2017-2022)
5.3 Americas Oncology Targeted Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Targeted Therapy Market Size by Region (2017-2022)
6.2 APAC Oncology Targeted Therapy Market Size by Type (2017-2022)
6.3 APAC Oncology Targeted Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncology Targeted Therapy by Country (2017-2022)
7.2 Europe Oncology Targeted Therapy Market Size by Type (2017-2022)
7.3 Europe Oncology Targeted Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Targeted Therapy by Region (2017-2022)
8.2 Middle East & Africa Oncology Targeted Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Oncology Targeted Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oncology Targeted Therapy Market Forecast
10.1 Global Oncology Targeted Therapy Forecast by Regions (2023-2028)
10.1.1 Global Oncology Targeted Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Oncology Targeted Therapy Forecast
10.1.3 APAC Oncology Targeted Therapy Forecast
10.1.4 Europe Oncology Targeted Therapy Forecast
10.1.5 Middle East & Africa Oncology Targeted Therapy Forecast
10.2 Americas Oncology Targeted Therapy Forecast by Country (2023-2028)
10.2.1 United States Oncology Targeted Therapy Market Forecast
10.2.2 Canada Oncology Targeted Therapy Market Forecast
10.2.3 Mexico Oncology Targeted Therapy Market Forecast
10.2.4 Brazil Oncology Targeted Therapy Market Forecast
10.3 APAC Oncology Targeted Therapy Forecast by Region (2023-2028)
10.3.1 China Oncology Targeted Therapy Market Forecast
10.3.2 Japan Oncology Targeted Therapy Market Forecast
10.3.3 Korea Oncology Targeted Therapy Market Forecast
10.3.4 Southeast Asia Oncology Targeted Therapy Market Forecast
10.3.5 India Oncology Targeted Therapy Market Forecast
10.3.6 Australia Oncology Targeted Therapy Market Forecast
10.4 Europe Oncology Targeted Therapy Forecast by Country (2023-2028)
10.4.1 Germany Oncology Targeted Therapy Market Forecast
10.4.2 France Oncology Targeted Therapy Market Forecast
10.4.3 UK Oncology Targeted Therapy Market Forecast
10.4.4 Italy Oncology Targeted Therapy Market Forecast
10.4.5 Russia Oncology Targeted Therapy Market Forecast
10.5 Middle East & Africa Oncology Targeted Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Oncology Targeted Therapy Market Forecast
10.5.2 South Africa Oncology Targeted Therapy Market Forecast
10.5.3 Israel Oncology Targeted Therapy Market Forecast
10.5.4 Turkey Oncology Targeted Therapy Market Forecast
10.5.5 GCC Countries Oncology Targeted Therapy Market Forecast
10.6 Global Oncology Targeted Therapy Forecast by Type (2023-2028)
10.7 Global Oncology Targeted Therapy Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Oncology Targeted Therapy Product Offered
11.1.3 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Oncology Targeted Therapy Product Offered
11.2.3 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Oncology Targeted Therapy Product Offered
11.3.3 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Oncology Targeted Therapy Product Offered
11.4.3 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Oncology Targeted Therapy Product Offered
11.5.3 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Oncology Targeted Therapy Product Offered
11.6.3 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oncology Targeted Therapy Product Offered
11.7.3 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Oncology Targeted Therapy Product Offered
11.8.3 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
11.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Oncology Targeted Therapy Product Offered
11.10.3 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Oncology Targeted Therapy Product Offered
11.11.3 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
11.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Oncology Targeted Therapy Product Offered
11.13.3 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Oncology Targeted Therapy Product Offered
11.14.3 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Oncology Targeted Therapy Product Offered
11.15.3 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Oncology Targeted Therapy Product Offered
11.16.3 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 Research Findings and Conclusion


List of Tables
Table 1. Oncology Targeted Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sorafenib
Table 3. Major Players of Lenvatinib
Table 4. Major Players of Regorafenib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Anlotinib
Table 7. Major Players of Alectinib
Table 8. Major Players of Other
Table 9. Oncology Targeted Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Oncology Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
Table 12. Oncology Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Oncology Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
Table 15. Global Oncology Targeted Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Oncology Targeted Therapy Revenue Market Share by Player (2020-2022)
Table 17. Oncology Targeted Therapy Key Players Head office and Products Offered
Table 18. Oncology Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Oncology Targeted Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Oncology Targeted Therapy Market Size Market Share by Regions (2017-2022)
Table 23. Americas Oncology Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Oncology Targeted Therapy Market Size Market Share by Country (2017-2022)
Table 25. Americas Oncology Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
Table 27. Americas Oncology Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
Table 29. APAC Oncology Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Oncology Targeted Therapy Market Size Market Share by Region (2017-2022)
Table 31. APAC Oncology Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
Table 33. APAC Oncology Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
Table 35. Europe Oncology Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Oncology Targeted Therapy Market Size Market Share by Country (2017-2022)
Table 37. Europe Oncology Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
Table 39. Europe Oncology Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Oncology Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Oncology Targeted Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Oncology Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Targeted Therapy
Table 48. Key Market Challenges & Risks of Oncology Targeted Therapy
Table 49. Key Industry Trends of Oncology Targeted Therapy
Table 50. Global Oncology Targeted Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Oncology Targeted Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Oncology Targeted Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Oncology Targeted Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Oncology Targeted Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Oncology Targeted Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 56. Bayer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 57. Bayer Oncology Targeted Therapy Product Offered
Table 58. Bayer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Eisai Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 62. Eisai Oncology Targeted Therapy Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Eisai Latest Developments
Table 66. Zelgen Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 67. Zelgen Oncology Targeted Therapy Product Offered
Table 68. Zelgen Main Business
Table 69. Zelgen Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Zelgen Latest Developments
Table 71. Cipla Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 72. Cipla Oncology Targeted Therapy Product Offered
Table 73. Cipla Main Business
Table 74. Cipla Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Cipla Latest Developments
Table 76. Natco Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 77. Natco Pharma Oncology Targeted Therapy Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Natco Pharma Latest Developments
Table 81. AstraZeneca Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 82. AstraZeneca Oncology Targeted Therapy Product Offered
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. AstraZeneca Latest Developments
Table 86. Novartis Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 87. Novartis Oncology Targeted Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Novartis Latest Developments
Table 91. Roche Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 92. Roche Oncology Targeted Therapy Product Offered
Table 93. Roche Main Business
Table 94. Roche Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Roche Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 102. Pfizer Oncology Targeted Therapy Product Offered
Table 103. Pfizer Main Business
Table 104. Pfizer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Pfizer Latest Developments
Table 106. BEACON Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 107. BEACON Pharma Oncology Targeted Therapy Product Offered
Table 108. BEACON Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. BEACON Pharma Main Business
Table 110. BEACON Pharma Latest Developments
Table 111. Jiangxi Shanxiang Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 112. Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
Table 113. Jiangxi Shanxiang Main Business
Table 114. Jiangxi Shanxiang Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Jiangxi Shanxiang Latest Developments
Table 116. Yao Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 117. Yao Pharma Oncology Targeted Therapy Product Offered
Table 118. Yao Pharma Main Business
Table 119. Yao Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Yao Pharma Latest Developments
Table 121. CSPC Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 122. CSPC Oncology Targeted Therapy Product Offered
Table 123. CSPC Main Business
Table 124. CSPC Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. CSPC Latest Developments
Table 126. CHIATAI Tianqing Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 127. CHIATAI Tianqing Oncology Targeted Therapy Product Offered
Table 128. CHIATAI Tianqing Main Business
Table 129. CHIATAI Tianqing Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. CHIATAI Tianqing Latest Developments
Table 131. Simcere Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 132. Simcere Oncology Targeted Therapy Product Offered
Table 133. Simcere Main Business
Table 134. Simcere Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Simcere Latest Developments
List of Figures
List of Figures
Figure 1. Oncology Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Targeted Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oncology Targeted Therapy Market Size Market Share by Type in 2021
Figure 7. Oncology Targeted Therapy in Hospital
Figure 8. Global Oncology Targeted Therapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Oncology Targeted Therapy in Retail Pharmacy
Figure 10. Global Oncology Targeted Therapy Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Oncology Targeted Therapy in Other
Figure 12. Global Oncology Targeted Therapy Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Oncology Targeted Therapy Market Size Market Share by Application in 2021
Figure 14. Global Oncology Targeted Therapy Revenue Market Share by Player in 2021
Figure 15. Global Oncology Targeted Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Oncology Targeted Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Oncology Targeted Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Oncology Targeted Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Oncology Targeted Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Oncology Targeted Therapy Value Market Share by Country in 2021
Figure 21. Americas Oncology Targeted Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Oncology Targeted Therapy Market Size Market Share by Application in 2021
Figure 23. United States Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Oncology Targeted Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Oncology Targeted Therapy Market Size Market Share by Application in 2021
Figure 29. China Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Oncology Targeted Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Oncology Targeted Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Oncology Targeted Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Oncology Targeted Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Oncology Targeted Therapy Market Size 2023-2028 ($ Millions)